Ikarian Capital, LLC Aslan Pharmaceuticals LTD Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.42 - $24.68 $63,122 - $3.71 Million	-150,292 Reduced 15.48%	820,455 $146,000
Q1 2022 May 13, 2022	BUY	$0.74 - $1.22 $39,515 - $65,146	53,399 Added 5.82%	970,747 $192,000
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $555,000 - $930,000	-500,000 Reduced 35.28%	917,348 $187,000
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $343,240 - $657,557	192,832 Added 15.75%	1,417,348 $288,000
Q1 2021 May 17, 2021	SELL	$1.86 - $5.25 $1.45 Million - $4.11 Million	-781,935 Reduced 38.97%	1,224,516 $243,000
Q4 2020 Feb 12, 2021	BUY	$1.54 - $2.22 $3.09 Million - $4.45 Million	2,006,451 New	2,006,451 $405,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.